Pfam Domains GO Terms
| Pyr redox 2 |
| Pyr redox |
| cellular response to aldosterone |
| oxidoreductase activity, acting on NAD(P)H |
| response to aldosterone |
| cellular response to mineralocorticoid stimulus |
| response to oxygen-glucose deprivation |
| cellular response to oxygen-glucose deprivation |
| NAD(P)H oxidase activity |
| cellular response to aldehyde |
| regulation of apoptotic DNA fragmentation |
| response to L-glutamate |
| regulation of DNA catabolic process |
| cellular response to nitric oxide |
| cellular response to reactive nitrogen species |
| response to nitric oxide |
| response to mineralocorticoid |
| FAD binding |
| intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress |
| cellular response to estradiol stimulus |
| regulation of execution phase of apoptosis |
| chromosome condensation |
| neuron apoptotic process |
| response to ischemia |
| response to bronchodilator |
| neuron death |
| positive regulation of neuron apoptotic process |
| cellular response to corticosteroid stimulus |
| cellular response to hydrogen peroxide |
| mitochondrial intermembrane space |
| cellular response to alcohol |
| activation of cysteine-type endopeptidase activity involved in apoptotic process |
| cellular response to ketone |
| positive regulation of neuron death |
| response to amino acid |
| cellular response to antibiotic |
| response to hydrogen peroxide |
| cellular response to reactive oxygen species |
| positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| response to estradiol |
| intrinsic apoptotic signaling pathway |
| positive regulation of cysteine-type endopeptidase activity |
| protein dimerization activity |
| response to corticosteroid |
| positive regulation of endopeptidase activity |
| DNA packaging |
| cellular response to steroid hormone stimulus |
| positive regulation of peptidase activity |
| response to ketone |
| response to reactive oxygen species |
| cellular response to decreased oxygen levels |
| regulation of neuron apoptotic process |
| cellular response to toxic substance |
| cellular response to oxygen levels |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| response to nutrient |
| cellular response to inorganic substance |
| response to alcohol |
| cellular response to nutrient levels |
| cellular response to oxidative stress |
| regulation of cysteine-type endopeptidase activity |
| response to endoplasmic reticulum stress |
| cellular response to extracellular stimulus |
| apoptotic signaling pathway |
| DNA conformation change |
| response to antibiotic |
| regulation of neuron death |
| response to steroid hormone |
| cellular response to external stimulus |
| response to acid chemical |
| regulation of DNA metabolic process |
| response to decreased oxygen levels |
| positive regulation of proteolysis |
| response to oxygen levels |
| response to oxidative stress |
| mitochondrial inner membrane |
| cellular response to drug |
| regulation of endopeptidase activity |
| regulation of peptidase activity |
| response to nutrient levels |
| response to toxic substance |
| cellular response to lipid |
| response to extracellular stimulus |
| response to inorganic substance |
| cellular response to organic cyclic compound |
| cellular response to hormone stimulus |
| positive regulation of apoptotic process |
| positive regulation of programmed cell death |
| cellular response to nitrogen compound |
| positive regulation of cell death |
| perinuclear region of cytoplasm |
| regulation of proteolysis |
| positive regulation of hydrolase activity |
| regulation of cellular catabolic process |
| response to lipid |
| response to hormone |
| response to organic cyclic compound |
| apoptotic process |
| oxidation-reduction process |
| regulation of catabolic process |
| response to organonitrogen compound |
| response to drug |
| programmed cell death |
| cellular response to oxygen-containing compound |
| chromosome organization |
| response to nitrogen compound |
| cell death |
| response to abiotic stimulus |
| cellular response to endogenous stimulus |
| mitochondrion |
| regulation of hydrolase activity |
| positive regulation of catalytic activity |
| DNA binding |
| response to endogenous stimulus |
| regulation of apoptotic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| positive regulation of cellular protein metabolic process |
| regulation of cell death |
| intracellular signal transduction |
| cellular response to stress |
| positive regulation of protein metabolic process |
| positive regulation of molecular function |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| HSD17B10 | 0.627 |
| SELRC1 | 0.593 |
| NDUFAF7 | 0.59 |
| MRPS34 | 0.587 |
| QRSL1 | 0.579 |
| MRP63 | 0.577 |
| SCO2 | 0.572 |
| MRPS6 | 0.568 |
| MRPL53 | 0.565 |
| MRPS14 | 0.563 |
| MRPS16 | 0.56 |
| GFM1 | 0.556 |
| DARS2 | 0.553 |
| C12orf65 | 0.549 |
| MRPS21 | 0.545 |
| DAP3 | 0.542 |
| LARS2 | 0.541 |
| YARS2 | 0.533 |
| TARS2 | 0.532 |
| MRPS5 | 0.532 |
| MRPL21 | 0.529 |
| NDUFA3 | 0.529 |
| FTSJ2 | 0.523 |
| MRPS25 | 0.52 |
| MRPL45 | 0.52 |
| VARS2 | 0.518 |
| PARS2 | 0.517 |
| EARS2 | 0.516 |
| SUPV3L1 | 0.516 |
| NDUFB11 | 0.51 |
| MARS2 | 0.508 |
| RBFA | 0.507 |
| COA3 | 0.505 |
| WBSCR16 | 0.504 |
| RNASEH1 | 0.503 |
| MRPL23 | 0.502 |
| NARS2 | 0.502 |
| COX16 | 0.501 |
| MRPS12 | 0.496 |
| AARS2 | 0.495 |
| MRPL47 | 0.487 |
| GFM2 | 0.486 |
| TFB1M | 0.486 |
| NDUFA1 | 0.485 |
| SARS2 | 0.484 |
| MRPS26 | 0.482 |
| NDUFAF4 | 0.482 |
| CHCHD1 | 0.482 |
| PET117 | 0.479 |
| RPUSD3 | 0.478 |
| NDUFC2 | 0.478 |
| POLG2 | 0.477 |
| MRPL42 | 0.476 |
| MTG2 | 0.474 |
| TOMM20 | 0.473 |
| MRPL44 | 0.473 |
| RARS2 | 0.472 |
| GTPBP10 | 0.469 |
| NDUFB6 | 0.468 |
| GATC | 0.466 |
| COA6 | 0.465 |
| MRPS9 | 0.465 |
| NDUFB5 | 0.463 |
| NDUFS2 | 0.462 |
| ATP5SL | 0.461 |
| MRPL17 | 0.46 |
| RTN4IP1 | 0.458 |
| RPUSD4 | 0.456 |
| COX7B | 0.456 |
| COX17 | 0.454 |
| PTCD3 | 0.454 |
| FARS2 | 0.452 |
| MTRF1L | 0.45 |
| MRPL20 | 0.449 |
| NDUFA2 | 0.448 |
| ELAC2 | 0.447 |
| KIAA0391 | 0.446 |
| MRPL22 | 0.444 |
| MALSU1 | 0.444 |
| MRPS18A | 0.443 |
| HARS2 | 0.442 |
| DDX28 | 0.442 |
| GRSF1 | 0.44 |
| FASTKD5 | 0.44 |
| ACAD9 | 0.439 |
| MRPL3 | 0.438 |
| SCO1 | 0.436 |
| PET112 | 0.435 |
| MRPS33 | 0.435 |
| MRPS2 | 0.434 |
| MRPL11 | 0.434 |
| FASTKD2 | 0.434 |
| NDUFA11 | 0.434 |
| SLC25A26 | 0.434 |
| C10orf2 | 0.434 |
| ECSIT | 0.429 |
| C17orf89 | 0.429 |
| NDUFB9 | 0.428 |
| PDSS1 | 0.427 |
| MRPS24 | 0.426 |
| COA5 | 0.426 |
| POLRMT | 0.426 |
| METTL17 | 0.425 |
| TRUB2 | 0.424 |
| UQCRC2 | 0.424 |
| MRPL15 | 0.422 |
| MRPS27 | 0.421 |
| BCS1L | 0.417 |
| RNMTL1 | 0.417 |
| MRPS22 | 0.416 |
| MRPL18 | 0.416 |
| MTIF2 | 0.416 |
| NDUFAF3 | 0.415 |
| WARS2 | 0.413 |
| MRPL36 | 0.412 |
| MRPL35 | 0.411 |
| MRPL43 | 0.411 |
| ATP5C1 | 0.411 |
| MRPS11 | 0.411 |
| SSBP1 | 0.409 |
| CARS2 | 0.409 |
| COX15 | 0.409 |
| MRPL4 | 0.408 |
| HIGD2A | 0.407 |
| MRPL33 | 0.406 |
| TUFM | 0.405 |
| MRPL12 | 0.404 |
| TIMM8B | 0.403 |
| NDUFAF6 | 0.403 |
| LRPPRC | 0.403 |
| MTPAP | 0.403 |
| NDUFA6 | 0.402 |
| PNPT1 | 0.401 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 1/1 |
| bile duct | 10/28 |
| blood | 5/26 |
| bone | 9/25 |
| breast | 6/30 |
| central nervous system | 16/49 |
| cervix | 2/4 |
| colorectal | 5/17 |
| esophagus | 8/11 |
| fibroblast | 0/1 |
| gastric | 3/14 |
| kidney | 12/18 |
| liver | 8/19 |
| lung | 26/72 |
| lymphocyte | 0/14 |
| ovary | 5/25 |
| pancreas | 12/22 |
| peripheral nervous system | 6/15 |
| plasma cell | 0/12 |
| prostate | 0/1 |
| skin | 3/20 |
| soft tissue | 2/7 |
| thyroid | 0/2 |
| upper aerodigestive | 13/22 |
| urinary tract | 9/28 |
| uterus | 0/5 |
Expression Distribution